Clinical Trials Browser

Terminated × Carcinoma × 30 days × Clear all

NCT03331601 2026-06-01

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients

Phase 2 Terminated

Brain Neoplasms, Carcinoma